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Background: Extracorporeal cardiopulmonary resuscitation (ECPR) refers to use of extracorporeal membrane
oxygenation (ECMO) in cardiopulmonary arrest. Although ECPR can increase survival rates after cardiac arrest, it can
also result in poor post-resuscitation neurological status. Thus, we investigated predictors of good neurological
outcomes after successful ECPR.
Methods: A total of 227 patients underwent ECPR from May 2004 to June 2013 at Samsung Medical Center.
Successful ECPR was defined as survival more than 24 hours after ECPR. Neurological outcomes were assessed at
discharge using the Glasgow-Pittsburgh Cerebral Performance Categories scale (CPC). CPC 1 and 2 were classified
as good and CPC 3 to 5 were classified as poor neurological outcomes. Excluded were 22 patients who did not
survive more than 24 hours after ECPR and 90 patients who died from unknown causes or causes other than brain
death or whose neurological status could not be assessed at discharge. Multiple logistic regression analysis was
used to identify independent predictors of neurological outcomes.
Results: Included were 115 patients with a mean age of 58 (range 45–66) years and 80 men (70%).
Cardiopulmonary resuscitation (CPR) was performed at non-hospital sites for 19 (17%) patients and bystander CPR
was performed in 9 of 19 cases (47%). Cardiac etiology was verified in 74 (64%) patients and therapeutic
hypothermia was performed in 9 patients (8%); 68 (59%) had good neurological outcomes and 47 (41%) did not
and 24 patients died from brain death. Neurological outcomes were affected by hemoglobin levels before ECMO
(P = 0.02), serum lactic acid (P < 0.001) before ECMO insertion, and interval from cardiac arrest to ECMO (P = 0.04).
Conclusions: Low hemoglobin or high serum lactic acid levels before ECMO, and prolonged interval from cardiac
arrest to ECMO predicted poor neurological outcomes after successful ECPR. Early institution of ECMO and a low
threshold for blood transfusion might improve neurological outcomes for patients who survive ECPR.
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Extracorporeal membrane oxygenation (ECMO) is a use-
ful intervention for refractory cardiogenic shock and
respiratory failure [1,2]. Because ECMO implementation
can rapidly normalize circulation in patients under cardiac
arrest, it has been used to assist cardiopulmonary resusci-
tation (CPR) [3-6]. Using traditional chest compression is
less effective than using ECMO with CPR (known as
extracorporeal CPR or ECPR). ECPR can achieve more
effective recovery of spontaneous circulation (ROSC) than
conventional CPR. ECMO implementation takes at least
several minutes when cardiopulmonary arrest is persistent,
even with conventional CPR. Since the brain is the organ
most vulnerable to hypoxia and inadequate perfusion,
ECPR can result in severe neurologic deficits if ECMO is
not performed promptly [7]. In addition to delay, several
factors may lead to poor neurological outcomes after
ECPR. Achieving good neurological outcomes and success-
ful resuscitation are important, so we investigated predic-
tors of favorable neurological outcomes rather than survival
after ECPR.
Methods
This retrospective study was performed in a cohort of
patients who underwent ECPR during hospitalization in
Samsung Medical Center (a 1961-bed, university-affiliated,
tertiary referral hospital in Seoul, South Korea). The study
was approved by the Institutional Review Board of Samsung
Medical Center (IRB No. SMC 2014-03-174-001) accordingFigure 1 Population inclusion and exclusion criteria. ECPR, extracorporto the Declaration of Helsinki on reviewing and publishing
information from patients’ records. Informed consent was
waived because of the retrospective nature of the study.
Patients
From May 2004 to June 2013, 227 adult patients under-
went ECPR at Samsung Medical Center. ECPR was de-
fined as use of venoarterial ECMO intended to treat
cardiac arrest. Successful ECPR was defined as survival
longer than 24 hours after ECPR. Excluded were 22 pa-
tients who did not survive more than 24 hours after
ECPR. Some patients who needed continuous sedation
because of hemodynamic instability could not be awak-
ened and spontaneous awakening trials were not pos-
sible. Some patients died from non-neurologic causes
such as multiorgan failure, cardiac death, or uncon-
trolled infection. We excluded patients for whom we
could not define neurological status because of continu-
ous sedation or death from unknown causes or causes
other than brain death. This resulted in 90 patients ex-
cluded and 115 patients included (Figure 1).
Endpoints and definitions
Our primary endpoint was neurological outcome at hos-
pital discharge, assessed with the Glasgow-Pittsburgh
Cerebral Performance Categories (CPC) scale (1 to 5, as
shown in Table 1) [8]. CPC 1 and 2 were classified as good
neurological outcomes. CPC 3, 4, and 5 were considered
poor neurological outcomes. We thoroughly reviewedeal cardiopulmonary resuscitation.





Conscious: Alert, able to work and lead a normal
life. May have minor psychological or neurological
deficits (mild dysphasia, nonincapacitating
hemiparesis, or minor cranial nerve abnormalities).
2.Moderate cerebral
disability
Conscious. Sufficient cerebral function for part-time
work in sheltered environment or independent
activities of daily life (dressing, traveling by public
transportation, preparing food). May have
hemiplegia, seizures, ataxia, dysarthria, dysphasia, or
permanent memory or mental changes.
3.Severe cerebral
disability
Conscious. Dependent on others for daily support
because of impaired brain function (in an
institution or at home with exceptional family
effort). At least limited cognition. Includes a wide
range of cerebral abnormalities from ambulatory
with severe memory disturbance or dementia
precluding independent existence, to paralytic and




Not conscious. Unaware of surroundings, no
cognition. No verbal or psychological
interactions with environment.
5. Death Certified brain dead or dead by traditional
criteria.
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scale upon agreement by two authors (JAR and YHC).
ECPR was defined ECMO performed during CPR. CPR
duration was defined as time from chest compression on-
set to offset. ROSC was defined for all rhythms as restor-
ation of spontaneous perfusing rhythm that resulted in
more than an occasional gasp, fleeting palpated pulse, or
arterial waveform. Interval from cardiac arrest to ECMO
was defined as time from collapse to the point of ECMO
setup and administration. ROSC time was defined as the
sum of time of ROSC before ECMO.
The ECMO team consisted of cardiovascular surgeons,
cardiologists, intensivists, special nurses, and perfusion-
ists. Percutaneous cannulation was established in the
femoral vein and artery by Seldinger’s technique. When
percutaneous puncturing the femoral artery was difficult,
femoral cutdown procedures were performed. Our
ECMO flow was described in a previous report [6]. The
institutional rapid response team called the oncall
ECMO team leader when CPR was performed for more
than 10 minutes or for unstable vital signs or recurrent
cardiac arrest. The ECMO team leader and CPR leader
assessed the patient and made a decision about ECPR.
ECPR was performed when cardiopulmonary arrest was
persistent despite conventional CPR over 10 minutes,
witness arrest was confirmed, and the event that caused
arrest was thought to be reversible. Generally, ECPR was
performed when probability of reversible cardiacetiology was high or cardiac arrest had a respiratory
cause. ECPR was deferred in cases of short life expect-
ancy (<6 months), uncontrolled terminal malignancy,
unwitnessed collapse, limited activity, unprotected air-
way, or more than 60 minutes of CPR time at initial
contact. Age alone was not a contraindication for ECPR.
The Capiox Emergency Bypass System (Terumo,
Tokyo, Japan) or Prolonged Life Support System
(Maquet Cardiopulmonary AG, Hirrlingen, Germany)
were used in all cases. Priming used a crystalloid solu-
tion such as normal saline or balanced solution. No pa-
tients in had blood-primed ECMO. Anticoagulation was
accomplished by unfractionated heparin bolus injection
followed by continuous intravenous heparin infusion to
maintain an activated clotting time between 150 and
200 seconds.
Statistical analysis
Continuous variables were expressed as medians and
interquartile ranges (IQRs). Chi-square or Fisher’s exact
test were used as appropriate for categorical data and
the Mann–Whitney U test was used for continuous data.
A multivariate logistic regression model was used to
identify predictors of neurological outcomes. All variables
associated with neurological outcomes were analyzed
by univariate analysis. Factors with P < 0.2 that were
considered clinically relevant were included in multi-
variate analysis. SPSS 20.0 software (SPSS Inc., Chicago,
IL, USA) was used for statistical analysis. A P-value of
less than 0.05 was considered statistically significant.
Results
Patient characteristics
The median patient age was 58 (range 45–66) years, and
80 patients (70%) were men. Interval from cardiac arrest
to ECMO was 34 (range 20–53) minutes. Cardiac
etiology was verified in 74 (64%) patients. Acute myocar-
dial infarction was the cause of cardiac arrest in 40 pa-
tients (35%) and 38 (33%) had a history of ischemic
heart disease. Respiratory etiology was verified in 5
patients (4%). Most patients (83%) had cardiac arrest in
the hospital and the few (17%) who had cardiac arrest in
a non-hospital setting had ECMO. Patient characteristics
are in Table 2.
ECPR and neurological outcomes
Of 115 patients, 68 (59%) had good neurological out-
comes but 47 (41%) did not (Figure 2). Therapeutic
hypothermia was performed in 10 patients (5%). Mean
duration of ECMO support was 47.5 (range 18.5–101)
hours. Total length of stay in intensive care unit (ICU)
was 11 (range 7–22.5) days and 24 patients died from
brain death. Univariate analysis showed no differences
between the good and poor neurological outcome
Table 2 Baseline characteristics of successful ECPR group and univariate analysis for factors associated with good and
poor CPC groups
Overall Good CPC group Poor CPC group P-value
Age (years) 58.0 (45.0-66.0) 58.0 (44.0-66.0) 58.5 (44.5-69.5) 0.32
Gender: Male (%) 80 (70) 47 (69) 33 (70) 0.90
Height (cm) 164.5 (157.0-170.0) 168.0 (157.0-173.0) 163.0 (155.5-169.5) 0.59
Weight (kg) 62.0 (55.1-69.7) 62.0 (54.9-71.0) 63.2 (55.9-69.6) 0.82
Comorbidities
DM (%) 51 (44) 30 (44) 21 (45) 0.95
HTN (%) 45 (39) 27 (40) 18 (38) 0.88
Smoking (%) 49 (43) 29 (43) 20 (43) 0.99
CKD (%) 8 (7) 6 (9) 2 (4) 0.47
PAOD (%) 4 (4) 2 (3) 2 (4) 0.71
Dyslipidemia (%) 11 (10) 8 (12) 3 (6) 0.52
Acute coronary syndrome 44 (38) 30 (44) 14(30) 0.12
STEMI (%) 22 (19) 17 (25) 5 (11)
NSTEMI (%) 18 (16) 9 (13) 9 (19)
Unstable angina (%) 4 (4) 4 (6) 0 (0)
Location of arrest
In hospital (%) 96 (83) 61 (90) 35 (75)
Out of hospital (%) 19 (17) 7 (10) 12 (26) 0.03
Location of ECMO insertion
Intensive care unit 48 (42) 29 (43) 19 (40) 0.81
Catheterization laboratory room 44 (38) 27 (40) 17 (36) 0.70
Emergency room 14 (12) 7 (10) 7 (15) 0.46
Operating room 7 (6) 5 (7) 2 (4) 0.70
General ward 2 (2) 0 (0) 2 (4) 0.82
Bystander CPR (%) 9 (8) 6 (9) 3 (6) 0.74
Therapeutic hypothermia (%) 9 (8) 5 (7) 4 (9) 0.82
Shockable rhythm (VF/VT) (%) 48 (42) 33 (49) 15 (32) 0.08
Laboratory data
Hemoglobin before ECMO (g/dL) 11.9 (10.3-14.3) 11.9 (10.2-14.8) 10.7 (9.2-12.3) 0.07
Hemoglobin after ECMO (g/dL) 10.4 (9.2-12.9) 10.0 (8.6-12.4) 9.7 (8.6-12.2) 0.13
T-bil (mg/dL) 0.9 (0.6-1.5) 0.8 (0.6-1.5) 0.9 (0.7-1.2) 0.60
BUN (mg/dL) 17.4 (12.5-24.6) 16.9 (13.8-28.0) 17.0 (11.4-22.1) 0.74
Cr (mg/dL) 1.1 (0.9-1.5) 1.2 (0.9-1.5) 1.2 (0.9-1.7) 0.65
Lactic acid (mmol/L) 8.5 (4.4-13.2) 8.0 (3.9-11.7) 13.6 (6.7-16.5) 0.002
CPR duration (min) 23.0 (15.0-41.0) 19.0 (15.0-28.0) 29.0 (21.0-51.0) 0.01
ROSC before ECMO insertion (%) 50 (44) 31 (46) 19 (40) 0.54
ROSC time (min) 0 (0–5.0) 0 (0–11.0) 0 (0–0) 0.54
Interval from cardiac arrest to ECMO (min) 34.0 (20.0-53.0) 24.5 (18.0-36.0) 40.0 (25.0-60.0) 0.01
ECPR, extracorporeal cardiopulmonary resuscitation; CPC, cerebral performance category; DM, diabetes mellitus; HTN, hypertension; CKD, chronic kidney disease;
PAOD, peripheral arterial occlusive disease; STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; ECMO, extracorporeal
membrane oxygenation; CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia; Hb, hemoglobin; T-bil, total bilirubin; BUN,
blood urea nitrogen; Cr, creatinine; ROSC, return of spontaneous circulation.
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Figure 2 Cerebral performance category score distribution in
good and poor neurological outcomes.
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peutic hypothermia, total bilirubin, creatinine, 24-hour
lactic acid clearance, ROSC before ECMO, or ROSC
time (Table 2).
Multivariate analysis revealed neurological outcomes
were affected by hemoglobin level, serum lactic acid be-
fore ECMO insertion, and interval from cardiac arrest to
ECMO (Figure 3). However, age, gender, cardiac arrest
out of the hospital, hemoglobin level after ECMO, acute
coronary syndrome, initial shockable rhythm, and CPR
duration were not independent predictors of neuro-
logical outcomes (Table 3).
Discussion
We excluded 90 patients whose neurological outcomes
could not be assessed or who died from unknown causes
or causes other than brain death. Neurological status
could not be assessed for a few patients because of poor
medical records. Death from unknown causes or causes
other than brain death was not possible to define as
meaningful CPC 5, because this study concerns ECPRFigure 3 Independent predictors of good neurological outcomes. Pre
membrane oxygenation; CI, confidence interval.and neurological outcomes instead of morbidity and
mortality. The study included 115 patients.
Chest compression results in 25–30% normal cardiac
output when performed under optimal conditions [4].
Prolonged CPR duration is related to cerebral damage and
low chance of ROSC [9]. However, ECMO can rapidly
normalize both blood flow and oxygenation. If successful,
ECMO can effectively protect major organs and often
reverse the underlying cause of cardiac arrest [4,5,10,11].
However, ECPR has two major limitations. One is the
need for anticoagulation. ECPR should not be performed
in patients with contraindications of anticoagulation
such as intracranial bleeding. The other is limited avail-
ability and time for preparation and insertion. ECPR de-
vices must be kept ready for use. ECMO team leaders
should be familiar with both surgical and catheter tech-
niques. ECMO in patients undergoing CPR can take lon-
ger and carry higher risks of procedural failure and
complications. A long time between cardiac arrest and
ECMO “pump on” may be tolerated by many major or-
gans except the brain, which is the organ most sensitive
to hypoxia. Thus, poor neurological outcomes with pre-
served function of vital organs other than the brain can
result from ECPR. Liberal use of ECMO as a CPR
method risks increasing the number of patients with se-
vere neurological deficits who require large amounts of
familial and social resources. Although several factors,
including initial rhythm, resuscitation duration, underlying
causes, and initial resuscitative efforts are associated with
both survival and neurological outcomes after ECPR [11],
we focused on predictors of favorable neurological out-
comes after successful ECPR.
Hemoglobin level before ECMO insertion was an im-
portant factor for neurological outcomes after successful
ECPR. We found no studies that investigated the rela-
tionship between hemoglobin level and neurological out-
comes after ECPR. Initial hemoglobin level is reported-lactic acid, lactic acid level before ECMO; ECMO, extracorporeal
Table 3 Multivariate analysis for factors associated with good neurological outcomes
OR (95 % CI) P-value
Age (years) 0.965 (0.931-1.001) 0.06
Gender Male (%) 0.576 (0.139-2.358) 0.45
Pre-lactic acid (mmol/L)* 0.764 (0.660-0.885) <0.001
Out of hospital CPR (%) 0.141 (0.017-1.187) 0.07
Hemoglobin before ECMO (g/dL)* 1.502 (1.070-2.108) 0.02
Hemoglobin after ECMO (g/dL) 0.932 (0.720-1.207) 0.59
Acute coronary syndrome (%) 3.387 (0.677-16.938) 0.14
Shockable rhythm (VF/VT) (%) 3.679 (0.881-15.360) 0.07
CPR duration (min) 1.003 (0.967-1.041) 0.86
Interval from cardiac arrest to ECMO (min)* 0.960 (0.922-0.999) 0.04
*Variables with P < 0.05; OR, odds ratio; CI, confidence interval; CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; VF, ventricular
fibrillation; VT, ventricular tachycardia.
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CPR [12]. The SOS-KANTO study showed higher
hemoglobin levels at hospital arrival are associated with
favorable short-term neurological outcomes among
postcardiac-arrest patients [12]. Animal studies also showed
that the penumbral brain is more vulnerable than the
normal brain, with oxygen delivery and cerebral meta-
bolic rate progressively declining as hemoglobin con-
centration decreases [13,14]. These mechanisms appear
to be physiological neuroprotective mechanisms against
ischemia caused by anemia. For ECPR patients, most
had prolonged cardiac arrest with bolus infusion of
crystalloid and colloid fluids. Because the crystalloid solu-
tion for ECMO priming dilutes the blood, hemoglobin
levels can decrease acutely. Low hemoglobin levels before
ECMO insertion might be associated with poor neuro-
logical outcomes. Efforts to correct anemia before or dur-
ing ECMO administration could enhance oxygen delivery
and be neuroprotective. Although high hemoglobin levels
were associated with good neurological outcome after
ECPR in our study, no investigations have examined if
higher hemoglobin levels from transfusions are neuropro-
tective. One hypothesis states that regular blood transfu-
sion may prevent silent ischemia and cognitive impairment
in patients with septic shock [15]. A controlled trial by
DeBaun et al. showed that regular blood-transfusion ther-
apy significantly reduced the incidence of recurrence of
silent and overt cerebral infarction in specific populations
(e.g., patients with sickle cell anemia, who require dialysis,
or have β-thalassemia) [16]. Recurrence of silent and overt
cerebral infarction is associated with cognitive impairment.
Transfusions have side effects and tolerating lower
transfusion triggers results in comparable or even better
outcomes, as shown multiple studies in other settings.
Thus, the association of good neurological outcomes with
higher hemoglobin levels induced by transfusion requires
further investigation.Lactic acid is a useful marker of tissue hypoxia. Levels
of lactic acid and its clearance from the blood are associ-
ated with mortality and neurological outcomes after
CPR [17]. Kliegel et al. showed that persistent hyperlac-
temia for 48 hours predicts mortality and poor neuro-
logical outcomes after conventional CPR [18]. Lactic
acid level and interval from cardiac arrest to ECMO are
significantly correlated [19]. Sawamoto et al. reported a
significant difference in serum lactic acid level between
patients with good and poor neurological outcomes who
had primary hypothermic cardiac arrest resuscitated
with ECPR [20]. This study showed neurological out-
comes are associated with serum lactic acid levels before
ECMO insertion. Several studies showed CPR duration
is associated with survival rate and neurological out-
comes [9,21].
Our analysis showed interval from cardiac arrest to
ECMO was prognostic, but CPR duration was not. CPR
duration did not include ROSC time. Since ROSC does
not necessarily mean stable vital signs with good oxygen
delivery, patients can still be hypotensive and hypoxic
from myocardium damage and pulmonary problems.
Therefore, in ECPR, brain perfusion can be affected by
interval from cardiac arrest to ECMO rather than CPR
duration. Thus, using ECMO without hesitation might
save brain function when a patient is still unstable after
ROSC.
This study had several limitations. CPC scale was retro-
spectively determined based on medical records. We ex-
cluded patients whose neurological status could not be
assessed because of deterioration followed by death. How-
ever, we included patients who had a diagnosis of brain
death. Therapeutic hypothermia may be associated with
neurological outcomes after cardiac arrest [22]. Therapeutic
hypothermia was performed on a limited number of pa-
tients in our study, for three reasons. First, hypothermia
can cause coagulopathy, so therapeutic hypothermia was
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insertion. Second, controlled surface cooling devices
were not available before 2009 in our hospital. From
2010, we have selectively used therapeutic hypothermia
in ECPR patients. Third, most ECPR patients had low
body temperature caused by extracorporeal circulation
and external volume infusion. Therefore, ECMO itself
could have some degree of neuroprotective effect
through hypothermia. Although a few studies investigated
ECPR and neurological outcomes, most included all ECPR
patients [4,10,11] and did not suggest prognostic factors
for favorable neurological outcomes. Those studies also
might have included patients who died during ECMO or
soon after ECMO weaning. Lacking a definition for
ECMO procedural success or salvage, we excluded pa-
tients who did not survive for more than 24 hours after
ECMO initiation.
Conclusions
In conclusion, low hemoglobin, high serum lactic acid
levels, prolonged interval from cardiac arrest to ECMO
were independent predictors for poor neurological out-
comes after successful ECPR. Early ECMO institution, low
blood transfusion threshold, and a sophisticated EMCO
program that enables accurate ECPR decisions and fast
ECMO procedures may improve patient neurological out-
comes for patients who survive cardiac arrest.
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